Beating DSS Inhibition: Reliable DNA Extraction From Fecal Sample

About the Webinar

DSS-induced colitis models are widely used in IBD research — but fecal samples from these studies are often highly inhibitor-rich and challenging to process. Low DNA yield, poor purity, and PCR inhibition can compromise downstream analysis and reproducibility.

In this technical webinar, we will share practical, workflow-based strategies to improve nucleic acid extraction from tough fecal matrices, including:

• How to overcome nucleic acid extraction challenges in DSS-induced IBD fecal samples

• Practical lysis preservation, and extraction strategies for inhibitor-rich stool matrices

• How to improve DNA yield, purity, and downstream results with DSS samples for microbiome and multi-omics studies

Speaker Details

Dr. Sonia Wong How Ming
Dr. Sonia Wong is an experienced researcher with a demonstrated history in biomedical research. She is highly skilled in research, public speaking, teamwork, and data analysis. She holds a PhD in Oncology from The University of Nottingham Malaysia Campus and has extensive experience in new product development and management, particularly in qPCR test kits, nucleic acid extraction kits, point-of-care device automation, and qPCR platforms in an ISO 13485-certified setting.

Bobby Lin
Bobby Lin, a seasoned Product Specialist with a strong background in cancer research. He holds a Master’s in Molecular Medicine and Bio engineering from National Chiao Tung University and specializes in bio active proteins, antibodies, ELISA kits, and GMP-grade products. His expertise spans product demonstration, handling, and lifecycle management, including IOPQ validation. As a former TPDA Lecturer, he has extensive experience conducting molecular, cell, and animal experiments, making him a knowledgeable and engaging speaker for those looking to deepen their understanding of biotechnological applications in medicine.